Video

Barry Borlaug, Mayo Clinic: Heart Failure With Preserved Ejection Fraction

Author(s):

While there's no yet proven treatment for heart failure with preserved ejection fraction, the team is really aiming to understand the pathophysiology to design better targeted treatments.

At the Heart Failure Society of America's 20th Annual Scientific Meeting in Orlando, Fl., Barry Borlaug, MD, Mayo Clinic, discussed his fascination with the relaxation of the heart and his latest research in heart failure with preserved ejection fraction. While there's no proven treatment, the team is really aiming to understand the pathophysiology to design better treatments. For now, the team is limited to controlling blood pressure and any diuretics and treating any of their other conditions until they can find more targeted treatments.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.